Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Breast Neoplasms 19Neoplasms 12Colorectal Neoplasms 5Pain, Postoperative 4Fatigue 4Thyroid Neoplasms 3Stomatitis 3Pain 3Malnutrition 3Liver Neoplasms 3Depression 3Carcinoma, Hepatocellular 3Anxiety Disorders 3Stomach Neoplasms 2Sleep Initiation and Maintenance Disorders 2Polycystic Ovary Syndrome 2Parasomnias 2Motor Activity 2Lung Neoplasms 2Gastrointestinal Neoplasms 2Breast Cancer Female 2Agnosia 2Weight Loss 1Vomiting 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Incontinence 1Unilateral U/S PVB 1Ulcer 1

Interventions

3-Iodobenzylguanidine 5Doxorubicin 3cabozantinib 2Temozolomide 2Radiotherapy 2Phenoxybenzamine 2Ifosfamide 2Filgrastim 2Everolimus 2Doxazosin 2Dexmedetomidine 2vatalanib 1temsirolimus 1pegfilgrastim 1lenvatinib 1fostamatinib 1atezolizumab 1anlotinib 1Vinorelbine 1Tamoxifen 1Sunitinib 1Stem Cell Transplantation 1Sirolimus 1Saline Solution 1Quality of Life 1Patient Reported Outcome Measures 1Oxaliplatin 1Observation 1Molecular Diagnostic Techniques 1Melphalan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Pheochromocytoma × Control Groups × Clear all
NCT04320589 2021-09-01

the Effect of Dexmedetomidine and Magnesium Sulfate in Open Resection of Pheochromocytoma

National Cancer Institute, Egypt

Phase 2 Completed
30 enrolled
Endocrine

Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡